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The human mitochondrial genome has been completely sequenced and each gene has 
been identified and characterized. The human mtDNA is a supercoiled, double-stranded 
circular molecule of 16,569 base pairs in size which codes for 13 of the 87 proteins 
required for oxidative phosphorylation as well as the 12s and 16s rRNAs and 22 tRNAs 
required for protein synthesis in the mitochondria. 
One of the common regions and hot spot of the mitochondrial genome so-called the 
common mitochondrial deletion (AmtDNA4977) was investigated which is at 
nucleotide number 8470 to 13447. This deletion affects important genes, involved in 
- 
OXPHOS (Oxidative Phosphorylation) such as ATPase 6, ATPase 8, Cytochrome 
Oxidase 111, and NADH subunits ND3, ND4, ND4L, and ND5 which may have a strong 
metabolic disadvantage. The prevalence of the AmtDNA4977 deletion has been 
investigated in different cancers. However in this study, we screened the common 
mitochondrial deletion to determine the prevalence of the common mitochondrial 
deletion in tumoral tissues as compared with adjacent non-tumoral tissues in gastric 
cancer by multiplex PCR amplification, polyacrylamide gel electrophoresis and 
Southern blot. 
In order to investigate whether a high incidence of mutation exists in mitochondrial 
DNA of gastric cancer tissues, DNA isolated from these cells was used to amplify 
hypervariable regions ATPase816, COXIII, ND3, ND4 and ND5 of AmtDNA4977. 
In 107 cancer patients, AmtDNA4977 was detected in 6 cases (5.60%) of the tumoral 
tissues and 18 cases (16.82%) of the non-tumoral tissues that were adjacent to the 
tumors. Levels of AmtDNA4977 deletions were found to be more in non-tumoral 
tissues than in adjacent tumoral tissues. There was no correlation between the clinical 
parameters like age, sex, tumor location and tumor size of patients. However there was 
an obvious relationship with intestinal-type of gastric cancer. 
The percentage of deleted genome in gastric tumoral tissues ranged from 25% to 74%. 
The level of the heteroplasmy was quantified by densitometry analysis with a Gel Doc 
2000 BIO-RAD instrument (Hercules, CA, USA). The level of heteroplasmy was 
determined as -25% to 74%. 
Unknown genetic aspects, ambiguous environmental factors and Reactive Oxygen 
Species (ROS) can cause the AmtDNA4977 mutation rate to be increased in gastric 
cancer. The results suggest that percentage level of AmtDNA4977 is less common and 
intolerable in tumoral tissue, probably because of high metaboIism and ROS generation. 
We postulate that the cells initially had AmtDNA4977, transformed to tumoral cell and 
the existence of this deletion confers metabolic disadvantage, thus cells that contain 
such mtDNA deletion would be overgrown by other cancer cells without this mtDNA 
deletion. As a result, the presence of AmtDNA4977 will be low in tumoral cell. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
KAJIAN MOLEKULAR TERHADAP DELESI BIASA MITOKONDRIAL 
(AMTDNA~~~') PADA SEL TUMOR BERBANDING DENGAN SEL 
SEBELAHAN BUKAN TUMOR DALAM KANSER PERUT PESAKIT- 
PESAKIT DI BAGHYATALLAH HOSPITAL IN TEHRAN 
Oleh 
BEHNAM KAMALIDEHGHAN 
Januari 2006 
Pengerusi: Profesor Madya Patimah Ismail, PhD 
Fakulti: Perubatan dan Sains Kesihatan 
Genom rnitokondria (mtDNA) manusia telah berjaya diuraikan jujukannya, dengan 
setiap gen telah dikenalpasti dan dicirikan. mtDNA mempunyai struktur molekul yang 
dipanggil supercoiled yang dibentuk oleh dua lapisan molekul DNA yang berpasangan 
di dalarn gelungan yang bersaiz 16,569 basepair untuk penghasilan 13 daripada 87 
protein untuk activiti yang dipanggil fosforilasi oksidatif, termasuk juga 12s dan 16s  
rRNA, dan 22 tRNA, di dalam rnitokondria. 
Salah satu daripada lokasi di dalam genom tersebut yang dikenali sebagai common 
mitochondria1 deletion (AmtDNA4977), yang terkandung di antara basepair 8470 dan 
13447, telah diselidiki. Ketiadaan pada lokasi ini membed kesan penting kepada gen- 
gen yang terlibat di dalarn OXPHOS (oxidative phosphorylation) seperti ATPase 6, 
ATPase 8, Cytochrome Oxidase 111, dan, subunit-subunit NADH - ND3, ND4, ND4L 
dan ND5, yang seterusnya menyebabkan masalah metabolik di dalam tubuh. 
Berlakunya kehilangan AmtDNA4977 telah diselidiki di dalam beberapa jenis kanser. 
Namun, di dalam penyelidikan ini kami mengenalpasti kehilangan ini untuk mencari 
kekerapannya pada sel tisu barah berbanding dengan sel tisu bukan barah pada barah 
usus dengan menggunakan teknik amplifikasi multiplex PCR, elektrophoresis gel 
polyacrylimide dan blot Southern. 
Bagi menyelidik samada kewujudan kejadian mutasi yang tinggi dalam DNA 
rnitokondrial pada tisu kanser perut, DNA telah diasingkan dari tisu ini dan di 
arnplifikasikan bahagian-bahagian kepelbagaian tinggi ATPase816, COXIII, ND3, ND4 
dan ND5 dari AmtDNA4977. Dalam 107 pesakit kanser dikaji, AmtDNA4977 telah 
dikesan pada 6 kes (5.60%) dari tisu tumor dan 18 kes (16.82%) dari tisu bukan tumor 
yang bersebelahan kepada tumor. Tahap delesi AmtDNA4977 didapati lebih pada tisu 
bukan tumor berbanding dalam tisu tumor bersebelahan. Didapati tiada korelasi di 
antara parameter klinikal seperti umur, seks, lokasi tumor dan saiz tumor pada pesakit, 
walaubagaimanapun adalah jelas terdapat perhubungan dengan jenis intestin dari kanser 
perut. 
Faktor genetic, alam sekitar yang talc diketahui dan Tindakbalas Spesis Oksigen(R0S) 
boleh sebabkan kadar mutasi AmtDNA4977 meningkat dalam kanser perut. Keputusan 
mencadangkan aras AmtDNA4977 adalah kurang biasa d m  tidak bertolak ansur dalam 
tisu tumor, mungkin disebabkan oleh metabolisma dan ROS yang tinggi. Kami postulat 
yang sel pada mulanya ada AmtDNA4977, telah bertukar pada sel tumor dan muncul 
delesi ini menjadikan metabolik tidak baik, jadi sel yang mengandungi delesi mtDNA 
vii 
tersebut akan membesar dengan bantuan sel kanser tanpa delesi mtDNA. Dan hasilnya, 
kehadiran AmtDNA4977 akan menjadi rendah dalam sel tumor. 
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CHAPTER 1 
INTRODUCTION 
Cancer is a serious health problem worldwide, imposing a large economical and 
psychological burden as well as loss of life and productivity (Whelan et al., 1993). 
Despite a decrease in the annual incidence and mortality rates over the past 50 years, 
gastric cancer remains the second cause of cancer-related death. As with other cancers, 
the etiology of gastric cancer is unknown (Rocco and Franco, 2004). 
Lots of effort and money have beeh put in the fields of clinical, epidemiological, 
pharmacological, and biological research on cancer in the recent decades. Although we 
have witnessed dramatic progress in the field, but still there is a long way to go. Cancer 
is the third most common cause of death in Iran, accounting for 14% of the total death 
toll (Naghavi, 2001). 
It stands just after cardiovascular events and accidents (46% and 17% of the total death 
toll respectively) according to the latest census of the Iranian Ministry of Health and 
Medical Education (IMHME). Overall, gastrointestinal (GI) cancers cause about half of 
all cancer deaths in Iran. Of the 17,450 GI cancers recorded in the IMHME report, 
7,560 (43.3%) were gastric cancers (Naghavi, 2001). In other words, of every 100 
people dying of cancer in Iran, 22 die of gastric cancer, and six from esophageal cancer. 
Unfortunately, both of these cancers come to medical attention when they are rather 
advanced and limited or no effective therapies are available for them. Theoretically, 
these cancers may be treatable in their early stage; therefore, finding them at the earliest 
possible stage may subject them to effective therapy. 
The Public Health Research Institute (PHRI) of Tehran University and the International 
Agency for Research on Cancer (IARC) jointly established a cancer registry in the city 
of Babol in Mazandaran Province in the Caspian littoral in 1969 (Joint Iran and IARC , 
1977). The registry mainly covered the two provinces of Gilan and Mazandaran, and the 
nearby city of Ardabil. Information gathered by this cancer registry soon showed an 
unusually high incidence of esophageal cancer in the Caspian Littoral. Interestingly the 
distribution was rather uneven. The western park of the Littoral (Ardabil) had a high 
incidence (age standardized ratio (ASR): 20.1 and 6.2 per 100,000 population for men 
and women, respectively), while the central parts had a lower incidence (ASR: 13.0 and 
2.3 per 100,000 for males and females, respectively), and the eastern parts had an 
unusually high incidence (ASR: 165.5 and 195.3 per 100,000 for men and women, 
respectively)(Habibi, 1965;Haghighi and Nasr, 197 1 ; Kemet and Mahboubi, 1972; 
Mahboubi et al., 1973; Joint Iran and IARC, 1977). This was especially evident in the 
Turkman plain in the East of the littoral having the above-mentioned ASR, which was 
among the highest ever recorded in the world. Another point of interest was that 
esophageal cancer was more common among Turkrnan females. 
A recent cancer surveillance study performed by the Ministry of Health of the Research 
Institute of Iran (Ministry of Health and Medical Education., 2000) revealed that gastric 
adenocarcinoma is the most common fatal cancer in Iran with a wide variation of death 
rate in different provinces. The mortality rate in Bushehr, southern Iran (Persian Gulf 
Coast), is 3.6 per 100,000 per year as compared to a rate of 8.4 per 100,000 in East 
Azarbaijan, northern Iran. According to a study in 1971, (Haghighi and Nasr, 1971) 
antral adenocarcinoma was considered the predominant type of gastric cancer in Iran. 
Some unpublished data from Ardabil in Easthern Azarbaijan on the west coast of the 
Caspian Sea, however, reported a higher frequency of gastric cardia cancer. This 
descriptive, endoscopic study was designed to further explore the anatomic subsite of 
different GI cancers in this high prevalence gastric cancer area. 
In Malaysia, of the three main ethnic groups, Malays, Chinese and Indians, the 
incidence of gastric ulcer was highest among the Chinese, next the Indians; however, 
the number of gastric cancers were too few for analysis of its racial incidence 
(Paramarajah, 1985). Other researches indicated that the incidence of surgery for gastric 
cancer in Singapore increased during the period 1951 to 1980 (males from 3.5 to 8.7 per 
100,000 per year: females from 0.5 to 4.2 per 100,000 per year). This increase occurred 
mainly during the first decade of the study and was confined to persons aged 55 and 
above. Chinese had the highest incidence, followed by Indians and then Malays (Kang, 
1988). 
Goh and Parasakthi (2001) had evaluated 2,381 subjects for Helicobacter pylori 
prevalence and found that it varied from different areas of study and ranged from a low 
of 26.4% in blood donors from Kota Baru to a high of 55.0% in Kota Kinabalu. The 
most striking differences, however, were noted in the prevalence rates among different 
